CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 78 filers reported holding CARDIFF ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 3.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,205 | -5.4% | 49,788 | 0.0% | 0.00% | – |
| Q2 2023 | $73,188 | -44.5% | 49,788 | -37.7% | 0.00% | – |
| Q1 2023 | $131,864 | +188.7% | 79,918 | +145.0% | 0.00% | – |
| Q4 2022 | $45,669 | -60.3% | 32,621 | -56.4% | 0.00% | – |
| Q3 2022 | $115,000 | -47.7% | 74,869 | -25.0% | 0.00% | – |
| Q2 2022 | $220,000 | +436.6% | 99,835 | +506.3% | 0.00% | – |
| Q1 2022 | $41,000 | -84.5% | 16,465 | -62.6% | 0.00% | – |
| Q4 2021 | $264,000 | -12.3% | 43,969 | -2.9% | 0.00% | – |
| Q3 2021 | $301,000 | +50.5% | 45,273 | +50.0% | 0.00% | – |
| Q2 2021 | $200,000 | -96.4% | 30,191 | -95.0% | 0.00% | -100.0% |
| Q1 2021 | $5,558,000 | +24065.2% | 600,208 | +46572.5% | 0.00% | – |
| Q4 2020 | $23,000 | -96.8% | 1,286 | -97.4% | 0.00% | – |
| Q3 2020 | $714,000 | – | 50,349 | +71827.1% | 0.00% | – |
| Q2 2020 | $0 | – | 70 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |